Influence of <i>ABCB1</i> and <i>CYP3A5</i> gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.

Pharmgenomics Pers Med · 2018 · PMC5868588 · PMID 29606886

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Differences in CYP3A activity in the groups did not reach statistical significance ( Table 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.